首页 › 间质性肺病 › 堪萨斯州 › Kansas City
Kansas City KS 间质性肺病临床试验
13项针对 间质性肺病的研究正在 Kansas City及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
招募中3 期
- University of Kansas Medical Center, Kansas City
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
招募中3 期
- University of Kansas Medical Center, Kansas City
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
招募中3 期
- USA002, Kansas City
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
招募中2 期
- University of Kansas Medical Center, Kansas City
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
招募中2 期
- Clinical Research Site, Kansas City
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
招募中观察性研究
- University of Kansas Medical Center, Kansas City
Platform Clinical Study for Conquering Scleroderma
招募中2 期
- University of Kansas School of Medicine, Kansas City
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
招募中2/3 期
- University of Kansas Medical Center, Kansas City
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
招募中2 期
- The University of Kansas Medical Center Research Institute, Kansas City
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
招募中3 期
- University of Kansas Medical Center, Kansas City
Interstitial Lung Disease Research Unit Biobank
招募中观察性研究
- The University of Kansas Medical Center, Kansas City
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
招募中1 期欢迎健康志愿者
- University of Kansas Medical Center, Kansas City
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
招募中观察性研究
- University of Kansas, Kansas City
其他城市的 间质性肺病试验
- New York City, NY18 项研究
- Philadelphia, PA16 项研究
- Los Angeles, CA14 项研究
- Charleston, SC13 项研究
- Durham, NC13 项研究
- Chicago, IL12 项研究
- Houston, TX12 项研究
- Aurora, CO11 项研究
- Ann Arbor, MI11 项研究
- Dallas, TX9 项研究
- Salt Lake City, UT9 项研究
- Boston, MA9 项研究
Kansas City的其他研究
- 心血管疾病14 项研究
- 心力衰竭13 项研究
- 肥胖症13 项研究
- 囊性纤维化13 项研究
- 乳腺癌12 项研究
- 膀胱癌12 项研究
- 急性髓系白血病12 项研究
- 前列腺癌12 项研究
- 非小细胞肺癌11 项研究
- 肺癌11 项研究
- 慢性阻塞性肺病9 项研究
- 哮喘8 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。